[1]
|
El-Serag, H.B. (2004) Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology, 127, S27S34. doi:10.1053/j.gastro.2004.09.013
|
[2]
|
Altekruse, S.F., McGlynn, K.A. and Reichman, M.E. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of Clinical Oncology, 27, 1485-1491.
doi:10.1200/JCO.2008.20.7753
|
[3]
|
Bruix, J. and Sherman, M. (2010) Management of heaptocellular carcinoma: An update, AASLD practice guidelines. Hepatology, 53, 1-3.
|
[4]
|
Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular carcinoma. Lancet, 362, 1907-1917.
doi:10.1016/S0140-6736(03)14964-1
|
[5]
|
Liu, X., Cheng, Y., Sheng, W., et al. (2010) Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: Analysis of 104 cases. Journal of Surgical Oncology, 102, 249.
doi:10.1002/jso.21624
|
[6]
|
Gilligan, T.D., Seidenfeld, J., Basch, E.M., et al. (2010) American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. Journal of Clinical Oncology, 28, 3388. doi:10.1200/JCO.2009.26.4481
|
[7]
|
Driscoll, D.A. and Gross, S.J. (2009) Professional Practice Guidelines Committee. Screening for fetal aneuploidy and neural tube defects. Genetics in Medicine, 11, 818. doi:10.1097/GIM.0b013e3181bb267b
|
[8]
|
Tong, M.J., Sun, H.-E., Hsien, C., et al. (2010) Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: Results from a community-based clinic. Digestive Diseases and Sciences, 55, 826-835.
|
[9]
|
Makuuchi, M., Kokudo, N., Arii, S., et al. (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatology Research, 38, 37-51.
doi:10.1111/j.1872-034X.2007.00216.x
|
[10]
|
Kudo, M. (2010) The 2008 okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy. Journal of Gastroenterology and Hepatology, 25, 439-452.
doi:10.1111/j.1440-1746.2009.06207.x
|
[11]
|
Bruix, J., Sherman, M., Llovet, J.M., et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology, 35, 421-430.
doi:10.1016/S0168-8278(01)00130-1
|
[12]
|
Zhang, B. and Yang, B. (1999) Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. Journal of Medical Screening, 6, 108-110.
|
[13]
|
Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology, 33, 464-470.
doi:10.1053/jhep.2001.22172
|
[14]
|
Child, C.G. and Turcotte, J.G. (1964) Surgery and portal hypertension. Major Problems in Clinical Surgery, 1, 185.
|
[15]
|
Nguyen, M. and Keeffe, E. (2002) Screening for hepatocellular carcinoma. Journal of Clinical Gastroenterology, 35, S86-S91. doi:10.1097/00004836-200211002-00004
|